Sign inJoin waitlistJoin the waitlist

Kathryn Mileham

Co-Leader · Wake Forest University Baptist Medical Center

Credentials: · · · ·

History

Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center
Present

Hematology and Medical Oncology
Vanderbilt University Medical Center
2006–2009
Internal Medicine
Vanderbilt University Medical Center
2003–2006
Med Univ of South Carolina Coll of Med
1999–2003

Research

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib
JAMA Oncology · 2018 · 598 citations
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆
Annals of Oncology · 2022 · 238 citations
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey
JCO Oncology Practice · 2020 · 168 citations

Richard Schilsky
10 papers
EK
Edward Kim
7 papers
Jimmy Ruiz
5 papers
Thomas Lycan
5 papers
CS
Charles Simone
4 papers
John Heinzerling
4 papers
Michael Chan
4 papers
TC
Timothy Cannon
4 papers
Caroline Dixon
3 papers · 1 as a resident
Daniel Carrizosa
3 papers
Michael Farris
3 papers
Olatunji Alese
3 papers

Clinical trials

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Principal investigator · Active not recruiting
Wake Forest University Health Sciences
2023–2035
LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer
Principal investigator · Completed · Phase 2
Wake Forest University Health Sciences
2014–2019
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Site PI · Recruiting
Wake Forest University Health Sciences
2025–2028
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Site PI · Recruiting · Phase 2
Wake Forest University Health Sciences
2023–2027